Evolus Inc (FRA:EVL)
€ 6.01 +0.010 (+0.17%) Market Cap: 404.22 Mil Enterprise Value: 505.30 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 72/100

Q1 2026 Evolus Inc Earnings Call Transcript

May 04, 2026 / 08:30PM GMT
Release Date Price: €4.51 (+2.73%)
Operator

Good afternoon, everyone, and thank you for standing by. Welcome to Evolus, first quarter earnings conference call. (Operator Instructions)

As a reminder, today's conference is being recorded and webcast live. (Operator Instructions)

I would now like to turn the conference over to Nareg Sagherian, Vice President, Head of Investor Relations, Corporate Communications. Please go ahead.

Nareg Sagherian
Evolus Inc - Investor Relations

Thank you, operator, and welcome to everyone joining us on today's call to review Evolus' first quarter financial results. Our first quarter press release is now on our website at evolus.com.

With me today are David Moatazedi, President and Chief Executive Officer; and Tatjana Mitchell, Chief Financial Officer; and Rui Avelar, Chief Medical Officer and Head of R&D, is also with us for the Q&A portion of the call.

Today's call will include forward-looking statements. Actual results may differ materially due to risks and uncertainties outlined in our earnings press release and SEC filings.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot